Licher, Silvan http://orcid.org/0000-0002-4586-4035
Terzikhan, Natalie
Splinter, Marije J.
Velek, Premysl
van Rooij, Frank J. A.
Heemst, Jolande Verkroost-van
Haarman, Annechien E. G.
Thee, Eric F.
Geurts, Sven
Mens, Michelle M. J.
van der Schaft, Niels
de Feijter, Maud
Pardo, Luba M.
Kieboom, Brenda C. T.
Ikram, M. Arfan
Funding for this research was provided by:
erasmus universiteit rotterdam
erasmus medisch centrum
zonmw (10430022010016)
the research institute for diseases in the elderly
ministerie van onderwijs, cultuur en wetenschap
european commission
municipality of rotterdam
Article History
Received: 18 June 2021
Accepted: 9 July 2021
First Online: 17 July 2021
Declarations
:
: Not applicable, none of the authors report conflicts of interest.
: The Rotterdam Study complies with the declaration of Helsinki and has been has been approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272–159,521-PG). The Rotterdam Study Personal Registration Data collection is filed with the Erasmus MC Data Protection Officer under registration number EMC1712001. The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; ExternalRef removed) and into the WHO International Clinical Trials Registry Platform (ICTRP; ExternalRef removed) under shared catalogue number NTR6831. All participants provided written informed consent to participate in the study and to have their information obtained from treating physicians.